Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis

ObjectivesFor colorectal cancer patients, traditional biomarker deficient mismatch repair/microsatellite instability (dMMR/MSI) is an accurate predictor of immune checkpoint inhibitors (ICIs). Recent years, researchers considered tumor mutation burden (TMB) as another predictive biomarker which mean...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yan Li, Yiqi Ma, Zijun Wu, Fanxin Zeng, Bin Song, Yanrong Zhang, Jinxing Li, Su Lui, Min Wu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2021-09-01
Serie:	Frontiers in Immunology
Soggetti:	tumor mutation burden immune checkpoint inhibitors overall survival objective response rate colorectal cancer
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.751407/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!